UCLA Department of Medicine - Hematology/Oncology

Santa Monica, California 90404

1 studies enrolling now · 6 studies all time

What they study most

Advanced Breast Cancer, Advanced Gastric Cancer, Advanced Solid Tumor, Adult, Breast Cancer, Breast Neoplasms, Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Dedifferentiated Liposarcoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Exocrine Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• A Study of Sigvotatug Vedotin in Advanced Solid Tumors — Recruiting now
• CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) — Recruiting now
• A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors — Running, not enrolling
• MGC018 With or Without MGA012 in Advanced Solid Tumors — Stopped early
• Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma — Stopped early
• Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer — Completed